Tau-PET imaging studies have shown that insoluble tau aggregates are strongly associated with cognitive decline even during the early pre-symptomatic stages of AD7 and tau-PET is the most accurate prognostic marker of AD available today8; however, PET imaging is highly expensive and needs a complex infrastructure, which reduces its use to only highly specialized centers. This evidence concerns the gene MAPT and Alzheimer disease.